ENTURIA is a medical company dedicated to preventative healthcare. Its focus is on the development, manufacturing and distribution of science-rich products that deliver “basically better health”.
Cutaneous antisepsis system
ChloraPrep is illustrative of this focus. It is a cutaneous antisepsis system designed to prevent infections associated with invasive procedures. ChloraPrep contains 2% chlorhexidine gluconate and 70% isopropyl alcohol delivered to the skin through a range of innovative, sterile, single patient use applicators. The company says that ChloraPrep is currently the only product licensed for cutaneous antisepsis, which allows healthcare professionals to comply with epic2: National Evidence-Based Guidelines for Preventing Healthcare Associated Infections.
